electronic records – Page 9

Step-by-Step Guide to Managing Manual Signature on Electronic Records Under ALCOA+ Expectations

Managing Manual Signature Issues on Electronic Records in Hybrid Paper–Electronic Systems In the realm of pharmaceutical manufacturing, the integration of hybrid paper–electronic systems has introduced complexities in managing records, particularly…

Why Transcription Error Prevention Happens and How QA Teams Should Control It

Understanding and Controlling Transcription Errors in Hybrid Paper Electronic Systems In the realm of pharmaceutical manufacturing and quality control, transcription errors can pose significant risks to data integrity, regulatory compliance,…

Inspection-Ready Approach to Hybrid Batch Record Governance in Pharmaceutical Operations

Effective Management of Hybrid Batch Record Systems in Pharmaceutical Manufacturing The adoption of hybrid batch record systems, integrating paper and electronic formats, raises significant challenges in maintaining data integrity under…

Paper Copy vs Electronic Source of Truth: Root Causes, GMP Risks, and CAPA Controls

Investigating Root Causes and Risks of Hybrid Paper and Electronic GMP Records In the pharmaceutical industry, maintaining data integrity is paramount, especially in hybrid systems that combine paper and electronic…

How to Prevent Controlled Printout Risks in Hybrid Paper–Electronic Systems

Mitigating Risks Associated with Controlled Printouts in Hybrid Paper–Electronic Systems The increasing adoption of hybrid paper–electronic systems in pharmaceutical operations presents specific challenges, particularly concerning controlled printout risks. These risks…

ERES Roadmap for Moving from Paper to Digital GMP Systems

Navigating the Transition from Paper to Digital GMP Systems in Pharma The pharmaceutical industry is increasingly striving to enhance efficiency and compliance through digital solutions, particularly in the realm of…

Electronic Records Inspection Questions and Best Responses

Understanding Compliance Issues in Electronic Records and Electronic Signatures in Pharma The increasing reliance on electronic records and electronic signatures (ERES) in pharmaceutical operations brings both significant advantages and considerable…

How to Monitor ERES Controls Using Quality Metrics

Effective Monitoring of Electronic Records and Signatures in Quality Systems In the pharmaceutical industry, controlling electronic records and signatures effectively is critical to maintaining compliance and ensuring product integrity. Any…

ERES Compliance for Analytical Instrument Data Systems

Ensuring Compliance with ERES for Analytical Instrument Data Systems In the fast-paced environment of pharmaceutical manufacturing, ensuring compliance with regulatory requirements related to electronic records and electronic signatures (ERES) is…

Electronic Records Decommissioning: Archive and Retrieval Strategy

Strategies for Decommissioning Electronic Records and Electronic Signatures in Pharma The landscape of pharmaceutical operations is increasingly influenced by digital solutions, particularly concerning electronic records and electronic signatures (ERES). However,…

How to Validate Electronic Signature Reason Codes and Meaning

Validation of Electronic Signature Reason Codes and Their Significance The increasing reliance on digital solutions in pharmaceutical environments has necessitated stringent validation processes for electronic records and electronic signatures (ERES).…

ERES Controls for Remote Review and Approval of GMP Documents

Ensuring Compliance with ERES Controls in GMP Document Management The pharmaceutical industry faces increasing pressure to comply with stringent regulations related to electronic records and electronic signatures, or ERES. This…